Doxycycline Hyclate, Doxycycline HCL EP / BP

Khoom	Doxycycline Hyclate
CAS	2058-46-0
Lub Npe Tshuaj	4S (4aR, 5S, 5aR, 6R, 12aS)] - 4- (dimethylamino) -1,4,4a, 5,5a, 6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy- 6-methyl-1,11deoxonaphthacene-2-carboxamide monohydrochloride, qhov sib xyaw nrog cov cawv cawv (2: 1 ）)
Cov mis qauv	C 22H 24N 2O 8· HCL · 1 / 2C 2H 5OH · 1 / 2H 2O
Molecular Luj	24390-14-5
Ntim	Export pob khoom nyog
Cov Ntaub Ntawv Kev Nyab Xeeb Cov Ntaub Ntawv	Muaj nyob ntawm kev thov
Cov lus	tetracycline tshuaj tua kab pab pawg

Doxycyline hydrochloride
Doxycycline hyclate yog ib qho hluavtaws tetracycline derivative nrog cov haujlwm sib luag.
 
Drug Indication 
1)Treatment of periodontal disease in dogs
 
2)Pigs: clinical signs with porcine respiratory disease. Chickens: to reduce mortality, morbidity, and clinical signs and to reduce lesions due to Pasteurellosis. Also in respiratory infections caused by Ornithobacterium rhinotracheale.
 
3)Treatment of infections of the respiratory tract and alimentary tract caused by micro-organisms susceptible to doxycycline.
 
4)Chickens: to reduce mortality, morbidity, and clinical signs and to reduce lesions due to Pasteurellosis caused by Pasteurella multocida or to reduce morbidity and lesions in respiratory infections caused by Ornithobacterium rhinotracheale (ORT)
 
5)Treatment of systemic amyloidosis caused by beta-2 microglobulin
 
6)Treatment of familial amyloid polyneuropathy